Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up

Diabetes Care

Volumn 26, Issue 10, 2003, Pages 2910-2914

  Qiao, Qing ^a   Jousilahti, Pekka ^a   Eriksson, Johan ^a   Tuomilehto, Jaakko ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTHROPOMETRIC PARAMETERS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; REVIEW; RISK ASSESSMENT; SCREENING; SMOKING; SYSTOLIC BLOOD PRESSURE;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 0141669157     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.10.2910     Document Type: Review

References (36)

1. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance: National Diabetes Data Group. Diabetes 28:1039-1057, 1979
2. Ohlson LO, Bjuro T, Larsson B, Eriksson H, Svardsudd K, Welin L, Wilhelmsen L: A cross-sectional analysis of glucose tolerance and cardiovascular disease in 67-year-old men. Diabet Med 6:112-120, 1989
3. Pan XR, Hu YH, Li GW, Liu PA, Bennett PH, Howard BV: Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese: Da Qing IGT and Diabetes Study. Diabetes Care 16:150-156, 1993
4. Rewers M, Shetterly SM, Baxter J, Marshall JA, Hamman RF: Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance arfd non-insulin-dependent diabetes mellitus in a biethnic Colorado population: the San Luis Valley Diabetes Study. Am J Epidemiol 135:1321-1330, 1992
5. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thibult N, Warnet JM, Claude JR, Rosselin GE: Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32:300-304, 1989
6. Jarrett RJ: The cardiovascular risk associated with impaired glucose tolerance. Diabet Med 13:S15-S19, 1996
7. Jarrett RJ, Fitzgerald AP: Height and glucose tolerance. Diabetologia 35:191-192, 1992
8. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A: Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care 22:920-924, 1999
9. Fujishma M, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Yoshitake T: Diabetes and Cardiovascular Disease in a Prospective Population Survey in Japan: the Hisayama Study. Diabetes 45 (Suppl.):S14-S16, 1996
10. Qiao Q, Pyorala K, Pyorala M, Nissinen A, Lindstrom J, Tilvis R, Tuomilehto J: Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 23:1267-1275, 2002
11. DECODE Study Group: Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 354:617-621, 1999
12. DECODE Study Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397-405, 2001
13. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H, Hemraj F, Fareed D, Tuomilehto J, Alberti KG: Impaired fasting glucose or impaired glucose tolerance: what best predicts future diabetes in Mauritius? Diabetes Care 22: 399-402, 1999
14. Vaccaro O, Ruffa G, Imperatore G, Iovino V, Rivellese A, Riccardi G: Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care 22:1490-1493, 1999
15. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC: The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23:1108-1112, 2000
16. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ: Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoom Study. JAMA 285:2109-2113, 2001
17. Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Tuomilehto J, Nissinen A: Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. Int J Epidemiol 23:495-504, 1994
18. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P: Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 309:23-27, 1994
19. Tuomilehto J, Korhonen HJ, Kartovaara L, Salomaa V, Stengard JH, Pitkanen M, Aro A, Javela K, Uusitupa M, Pitkaniemi J: Prevalence of diabetes mellitus and impaired glucose tolerance in the middleaged population of three areas in Finland. Int J Epidemiol 20:1010-1017, 1991
20. WHO Consultation: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization, 1999 (Report No. 99.2)
21. Mahonen M, Salomaa V, Torppa J, Miettinen H, Pyorala K, Immonen-Raiha P, Niemela M, Ketonen M, Arstila M, Kaarsalo E: The validity of the routine mortality statistics on coronary heart disease in Finland: comparison with the FINMONICA MI register data for the years 1983-1992. J Clin Epidemiol 52:157-166, 1999
22. Rapola JM, Virtamo J, Korhonen P, Haapakoski J, Hartman AM, Edwards BK, Heinonen OP: Validity of diagnoses of major coronary events in national registers of hospital diagnoses and deaths in Finland. Eur J Epidemiol 13:133-138, 1997
23. McPhillips JB, Barrett-Connor E, Wingard DL: Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol 131:443-453, 1990
24. Haffner SM: The prediabetic problem: development of non-insulin-dependent diabetes mellitus and related abnormalities. J Diabetes Complications 11:69-76, 1997
25. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263:2893-2898, 1990
26. Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, Motz E: Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 106:1211-1218, 2002
27. Pan X, Li G, Hu Y, Wang J, Yang W, An Z, Hu Z, Lin J, Xiao J, Cao H, Liu P, Jiang X, Jiang Y, Wang J, Zheng H, Zhang H, Bennett P, Howard B: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544, 1997
28. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
29. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
30. Evans A, Tolonen H, Hense H-W, Ferrario M, Sans S, Kuulasmaa K: Trends in coronary risk factors in the WHO MONICA Project. Int J Epidemiol 30:355-405, 2001
31. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, Evans A, Ferrario M, Tuomilehto J: Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 355:675-687, 2000
32. Salomaa V, Ketonen M, Koukkunen H, Immonen-Raiha P, Jerkkola T, Karja-Koskenkari P, Mahonen M, Niemela M, Kuulasmaa K, Palomaki P, Arstila M, Vuorenmaa T, Lehtonen A, Lehto S, Miettinen H, Torppa J, Tuomilehto J, Kesaniemi YA, Pyorala K: Trends in coronary events in Finland during 1983-1997: the FINAMI study. Eur Heart J 24:311-319, 2003
33. Tolonen H, Mahonen M, Asplund K, Rastenyte D, Kuulasmaa K, Vanuzzo D, Tuomilehto J: Do trends in population levels of blood pressure and other cardiovascular risk factors explain trends in stroke event rates? Comparisons of 15 populations in 9 countries within the WHO MONICA stroke project. Stroke 33: 2367-2375, 2002
34. Kylin E: Studies of the hypertension-hyperglycemia-hyperuricemia syndrome. Zentral-blatt fuer Innere Medizin 44:105-127, 1923
35. Reaven GM: Banting lecture: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
36. Dinneen SF, Maldonado D, Leibson CL, Klee GG, Li H, Melton LJ, Rizza RA: Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care 21:1408-1413, 1998